The Bioresorbable Implants for Scaffolding Obstructions in Randomized Bifurcations (BIFSORB) Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 120 participants.
Also called NCT02973529
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 120 participants
- Registry
-
NCT02973529
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Denmark, Latvia
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT02973529. Randomized; no masking; primary purpose treatment. Start 2016-01 (registry gives no type); primary completion 2026-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Bioresorbable Implants for Scaffolding Obstructions in Randomized Bifurcations (BIFSORB) Study
- Acronym
- BIFSORB
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Absorb
- Intervention (Device)
- Desolve
- Lead sponsor
- Aarhus University Hospital Skejby
Record details
- Record id
cardio:ct-nct02973529- Content hash
417fedba6fec182f137962113e430f152b6b84a1f7f9685b2ae803a801063464